source
- STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaBig drugmakers tell U.S. House committee they will halt clinical trials at some hospitals in China.STAT · 1h ago↗ source
- FDA approves treatments for four rare diseases; Pfizer inks $2.6 billion China licensing deal for CAR‑T therapyThe U.S. Food and Drug Administration has granted approval for drugs targeting four distinct rare diseases, expanding therapeutic options for patients with limited treatment choices. In a separate…